Target intelligence / Profile preview

Serpin family B member 5 (SERPINB5)

Target
SERPINB5
Molecular classification
Serine protease inhibitor (serpin), Clade B serpin, Non-inhibitory serpin, Other (Obligately intracellular protein)
01

Overview

Serpin family B member 5 (SERPINB5), also known as maspin, is a non-inhibitory member of the serpin superfamily of serine protease inhibitors, primarily encoded in humans by the SERPINB5 gene[1][3]. Originally identified as a tumor suppressor that inhibits cell invasion, migration, and metastasis, particularly in epithelial cells, its precise physiological function remains unclear due to conflicting findings from animal models and mechanistic studies[1][3][5]. Unlike classical serpins, maspin is mainly found intracellularly with nucleocytoplasmic distribution and is not secreted nor present at the cell surface[3]. It is proposed to modulate cell-matrix interactions, regulate cell adhesion and apoptosis, and affect chromatin state or gene expression, but it lacks direct protease inhibitory activity[1][3][5]. Maspin expression is regulated by tumor suppressors such as p53 and is subject to complex epigenetic control. Although frequently investigated as a tumor (especially breast and prostate cancer) prognostic marker or potential therapeutic target, there are no drugs currently approved that target SERPINB5 directly[1][5].

Other names
Serpin B5maspinPI-5peptidase inhibitor 5protease inhibitor 5 (maspin)serine (or cysteine) proteinase inhibitor clade B member 5serpin peptidase inhibitor clade B member 5
02

Mechanism of action

Not directly targeted by drugs; proposed to act via modulation of gene expression, inhibition of cell motility and invasion, regulation of apoptosis, potential inhibition of histone deacetylase 1 (HDAC1)[1][3][5]

03

Biological functions

Putative tumor suppressionRegulation of cell adhesionRegulation of cell invasion and motilityModulation of apoptosisEpigenetic regulation (chromatin/gene expression)Regulation of oxidative stress(Proposed) interaction with extracellular matrix
04

Disease associations

Cancer (breast, prostate, ovarian, non-small cell lung, gastric, pancreatic)Tumor suppression
05

Safety considerations

Lack of detailed molecular mechanism complicates therapeutic targetingConflicting evidence regarding its essential role and function in vivo[1][3]
06

Biomarkers

Loss or retention of maspin expression in tumors (prognostic marker in some cancers, e.g., breast and prostate)[3][5]Methylation status of the SERPINB5 promoter[5]

Beyond the preview

Go deeper on Serpin family B member 5 (SERPINB5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serpin family B member 5 (SERPINB5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call